Pregnant women with immune mediated inflammatory diseases who discontinue biologics have higher rates of disease flare.

Among pregnant women with IMIDs, those that continued biologics during pregnancy had increased rates of major infection, disease related hospital admission, glucocorticoid use, and disease flare within 6 months post-partum, without any significant change in maternal or neonatal outcomes.